As of today (2024-04-23), Intelgenx Technologies's share price is $0.15.
Intelgenx Technologies's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.04. Hence, Intelgenx Technologies's Price-to-Free-Cash-Flow Ratio for today is N/A.
The historical rank and industry rank for Intelgenx Technologies's Price-to-Free-Cash-Flow or its related term are showing as below:
During the past 13 years, Intelgenx Technologies's highest Price-to-Free-Cash-Flow Ratio was 99999999.99. The lowest was 0.00. And the median was 99999999.99.
IGXT's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 30.29 * Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 11.10% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 19.40% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was -8.80% per year.
During the past 13 years, Intelgenx Technologies's highest 3-Year average Free Cash Flow per Share Growth Rate was 30.70% per year. The lowest was -117.80% per year. And the median was 11.85% per year.
Intelgenx Technologies Price-to-Free-Cash-Flow Historical Data
The historical data trend for Intelgenx Technologies's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Intelgenx Technologies's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Intelgenx Technologies Price-to-Free-Cash-Flow Distribution
For the Biotechnology industry and Healthcare sector, Intelgenx Technologies's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Intelgenx Technologies's Price-to-Free-Cash-Flow falls into.
Intelgenx Technologies's Share Price of today is $0.15.
Intelgenx Technologies's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.04.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Intelgenx Technologies Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Intelgenx Technologies's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Intelgenx Technologies (Intelgenx Technologies) Business Description
Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. Intelegenx focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IGXT has been successfully added to your 